Balchem Q3 revenue up 23.4% to $244.3M; adjusted EPS $1.00 vs $0.92 YoY

BALCHEM CORP

2022-Q3 EPS reported $2.59 revenue$709,827,000

Net sales $244.3M (+23.4% YoY); GAAP EPS $0.78, adjusted EPS $1.00.
Adjusted EBITDA $53.8M (+11.2% YoY); net earnings $25.2M (+0.9%).
Completed Bergstrom (OptiMSM) acquisition on Aug 30, 2022, adding MSM capabilities.
Cash from ops $41.6M; free cash flow $26.8M; net debt $406.1M (leverage 1.9x).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

BALCHEM CORP reported the quarter ended September 30, 2022 results: revenue $244.3 million, net income $25.2 million, EPS $0.78.

Period: the quarter ended September 30, 2022
Revenue: $244.3 million
Net income: $25.2 million
EPS: $0.78
Result: reported results

Exact text from the filing

in such a filing. --- EX-99.1 (EX-99.1) --- Human Nutrition & Health | Animal Nutrition & Health | Specialty Products Balchem Corporation Reports Third Quarter Sales of $244.3 Million, Net Earnings of $25.2 Million, GAAP EPS of $0.78, and Adjusted EPS of $1.00 Montvale, NJ, November 4, 2022 - Balchem Corporation (NASDAQ: BCPC) reported today third quarter net

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

BALCHEM CORP filing history →

Source: SEC EDGAR

accession 0001628280-22-028349

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.